H.U. Group Holdings Inc. 2022 IR
The report outlines H.U. Group Holdings' progress under its medium-term plan 'H.U.2025' and its transition to a new global strategy in the in vitro diagnostics (IVD) business. Key achievements include the phased operational start of the fully automated H.U. Bioness Complex and the acquisition of ADx NeuroSciences NV to strengthen its Alzheimer's disease-related R&D. The company also established a joint venture, Medisket, with MEDIPAL HOLDINGS to optimize logistics and reduce greenhouse gas emissions. In sustainability, the Group achieved an A- score in the CDP Climate Change Report 2021 and made progress toward its long-term environmental goals.
Company: H.U. Group Holdings Inc.
Sector: Healthcare & social services
Country: Japan
Year: 2022
Type: IR
Pages: 60
Back to company
H.U. Group Holdings Inc.
Integrated Report
The report outlines H.U. Group Holdings' progress under its medium-term plan 'H.U.2025' and its transition to a new global strategy in the in vitro diagnostics (IVD) business. Key achievements include the phased operational start of the fully automated H.U. Bioness Complex and the acquisition of ADx NeuroSciences NV to strengthen its Alzheimer's disease-related R&D. The company also established a joint venture, Medisket, with MEDIPAL HOLDINGS to optimize logistics and reduce greenhouse gas emissions. In sustainability, the Group achieved an A- score in the CDP Climate Change Report 2021 and made progress toward its long-term environmental goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women in Management
Net Zero Target
Employees